TVTX logo

Travere Therapeutics (TVTX)

Profile

Full Name

Travere Therapeutics, Inc.

Ticker Symbol

TVTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 8, 2012

Indexes

Not included

Website

http://www.travere.com

Employees

385

Key Details

Price

$14.49(+1.26%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$233.18M(+60.55% YoY)

Annual EPS

-$4.08(-172.00% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.49
    TVTX price is $14.49

    30-Day Relative Volume

    0.49
    TVTX 30-day relative volume is 0.49

    Price Performance

    Price Today change

    +1.26%
    TVTX price is up +1.26% today

    Price YTD change

    -16.82%
    TVTX price is down -16.82% since January 1st

    Price 1-year change

    +98.22%
    TVTX price is up +98.22% year-on-year

    Price 3-year change

    -44.33%
    TVTX price is down -44.33% over the past 3 years

    Price Range

    Price All-time high

    $37.04
    TVTX price is currently -60.88% below its historical high of $37.04

    Price 3-year low

    $5.12
    TVTX price is currently +183.01% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.29B
    TVTX market capitalization is $1.29 billion

    Market cap 3-year change

    -22.17%
    TVTX market capitalization is down -22.17% over the past 3 years

    Market cap All-time high

    $2.16B
    TVTX market capitalization is currently -40.45% below its historical high of $2.16 billion

    Market cap sector rank

    78.27%
    TVTX market capitalization is higher than 78.27% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +16.65%
    TVTX shares outstanding is up +16.65% year-on-year

    Shares Outstanding 3-Year Change

    +39.82%
    TVTX shares outstanding is up +39.82% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.12
    TVTX beta is 1.12

    200-day SMA

    $17.79
    TVTX price is currently -18.54% below its 200-day simple moving average

    50-day SMA

    $16.84
    TVTX price is currently -13.97% below its 50-day simple moving average

    RSI

    40.25
    TVTX 14-day relative strength index is 40.25

    Volume

    0.49
    TVTX 30-day relative volume is 0.49

    ATR

    $0.78
    TVTX average true range is $0.78

    10-day Historical Volatility

    42.75%
    TVTX 10-day historical volatility is 42.75%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $233.18M
    TVTX annual revenue is $233.18 million

    Revenue Analysts estimate

    $397.34M
    TVTX annual revenue is currently -41.32% lower than the consensus analysts' forecast

    Revenue 1-year change

    +60.55%
    TVTX annual revenue is up +60.55% year-on-year

    Revenue Sector rank

    66.21%
    TVTX annual revenue is higher than 66.21% of companies in Healthcare sector

    EPS

    EPS

    -$4.08
    TVTX annual earnings per share is -$4.08

    EPS Analysts estimate

    -$0.24
    TVTX annual earnings per share is currently +1615.73% higher than the consensus analysts' forecast

    EPS 1-year change

    -172%
    TVTX annual earnings per share is down -172% year-on-year

    EPS Sector rank

    22.76%
    TVTX annual earnings per share is higher than 22.76% of companies in Healthcare sector

    Profit

    Gross profit

    $225.43M
    TVTX annual gross profit is $225.43 million

    Gross margin

    96.68%
    TVTX annual gross profit margin is 96.68%

    Operating profit

    -$321.39M
    TVTX annual operating income is -$321.39 million

    Operating margin

    -137.83%
    TVTX annual operating profit margin is -137.83%

    Net income

    -$321.55M
    TVTX annual net profit is -$321.55 million

    Net margin

    -137.90%
    TVTX annual net profit margin is -137.90%

    Expenses

    Total expenses

    $554.56M
    TVTX annual total expenses is $554.56 million

    Operating expenses

    $546.82M
    TVTX annual total operating expenses is $546.82 million

    Cost of goods sold

    $7.74M
    TVTX annual cost of goods sold is $7.74 million

    Selling, general & administrative expenses

    $264.12M
    TVTX annual SGA is $264.12 million

    Depreciation and amortization

    $43.55M
    TVTX annual depreciation & amortization is $43.55 million

    Interest expense

    $11.18M
    TVTX annual interest expense is $11.18 million

    Income tax

    $120.00K
    TVTX annual income tax is $120.00 thousand

    EBIT & EBITDA

    EBIT

    -$309.33M
    TVTX annual earnings before interest & taxes is -$309.33 million

    EBITDA

    -$265.77M
    TVTX annual EBITDA is -$265.77 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $594.13M
    TVTX annual total assets is $594.13 million

    Non current assets

    $177.47M
    TVTX annual long term assets is $177.47 million

    Current assets

    $416.70M
    TVTX annual total current assets is $416.70 million

    Cash and cash equivalents

    $58.53M
    TVTX annual cash & cash equivalents is $58.53 million

    Accounts receivable

    $27.12M
    TVTX annual accounts receivable is $27.12 million

    Inventory

    $6.20M
    TVTX annual inventory is $6.20 million

    Liabilities

    Total liabilities

    $535.05M
    TVTX annual total liabilities is $535.05 million

    Long term liabilities

    $334.30M
    TVTX annual total long term liabilities is $334.30 million

    Current liabilities

    $200.75M
    TVTX annual total current liabilities is $200.75 million

    Accounts payable

    $23.53M
    TVTX annual accounts payable is $23.53 million

    Debt

    Total debt

    $401.58M
    TVTX annual total debt is $401.58 million

    Total debt 1-year change

    -0.79%
    TVTX annual total debt is down -0.79% year-on-year

    Long term debt

    $327.50M
    TVTX annual long term debt is $327.50 million

    Short term debt

    $74.08M
    TVTX annual short term debt is $74.08 million

    Equity & Capital

    Shareholders equity

    $59.08M
    TVTX annual stockholders equity is $59.08 million

    Book value

    $59.08M
    TVTX annual book value is $59.08 million

    Retained earnings

    -$1.45B
    TVTX annual retained earnings is -$1.45 billion

    Working capital

    $215.95M
    TVTX annual working capital is $215.95 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$237.47M
    TVTX annual cash flow from operations is -$237.47 million

    Cash from operations 1-year change

    +15.19%
    TVTX annual cash flow from operations is up +15.19% year-on-year

    Cash from investing

    $99.33M
    TVTX annual cash flow from investing activities is $99.33 million

    Cash from investing 1-year change

    +78.08%
    TVTX annual cash flow from investing activities is up +78.08% year-on-year

    Cash from financing

    $139.42M
    TVTX annual cash flow from financing activities is $139.42 million

    Cash from financing 1-year change

    -36.26%
    TVTX annual cash flow from financing activities is down -36.26% year-on-year

    CAPEX

    CAPEX

    $101.21M
    TVTX annual capital expenditures is $101.21 million

    CAPEX 1-year change

    +143.35%
    TVTX annual capital expenditures is up +143.35% year-on-year

    Free Cash Flow

    Free cash flow

    -$338.69M
    TVTX annual free cash flow is -$338.69 million

    Free cash flow 1-year change

    -5.31%
    TVTX annual free cash flow is down -5.31% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    96.68%
    TVTX annual gross profit margin is 96.68%

    Operating margin

    -137.83%
    TVTX annual operating profit margin is -137.83%

    Net margin

    -137.90%
    TVTX annual net profit margin is -137.90%

    ROA & ROE

    ROA

    -46.50%
    TVTX annual return on assets is -46.50%

    ROE

    -247.45%
    TVTX annual return on equity is -247.45%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TVTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TVTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    39.20
    TVTX price to book ratio is 39.20

    PB ratio Sector rank

    97.71%
    TVTX price to book ratio is higher than 97.71% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.70
    TVTX price to sales ratio is 4.70

    PS ratio Sector rank

    63.19%
    TVTX price to sales ratio is higher than 63.19% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.63B
    TVTX enterprise value is $1.63 billion

    Enterprise value Sector rank

    79.09%
    TVTX enterprise value is higher than 79.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.66
    TVTX EV/EBITDA is -9.66

    EV/EBITDA Sector rank

    13.45%
    TVTX EV/EBITDA is higher than 13.45% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.08
    TVTX annual current ratio is 2.08

    Quick ratio

    2.04
    TVTX annual quick ratio is 2.04

    Leverage

    Debt to equity

    6.42
    TVTX annual debt to equity ratio is 6.42

    Interest coverage ratio

    -27.66
    TVTX annual interest coverage ratio is -27.66

    Risk & Stability

    Piotroski F-Score

    3
    TVTX piotroski f-score is 3

    Altman Z-Score

    -2.86
    TVTX altman z-score is -2.86

    Analyst ratings

    Recent major analysts updates

    May 16, 25 Wedbush
    Outperform
    May 2, 25 Wedbush
    Outperform
    May 2, 25 Stifel
    Hold
    Apr 23, 25 Cantor Fitzgerald
    Overweight
    Apr 14, 25 Guggenheim
    Buy
    Apr 10, 25 Canaccord Genuity
    Buy
    Apr 3, 25 Cantor Fitzgerald
    Overweight
    Apr 1, 25 B of A Securities
    Buy
    Feb 26, 25 JP Morgan
    Overweight
    Feb 24, 25 Citigroup
    Buy

    Institutional Ownership

    Screeners with TVTX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Travere Therapeutics?
    • Does Travere Therapeutics pay dividends?
    • What sector is Travere Therapeutics in?
    • What industry is Travere Therapeutics in?
    • What country is Travere Therapeutics based in?
    • When did Travere Therapeutics go public?
    • Is Travere Therapeutics in the S&P 500?
    • Is Travere Therapeutics in the NASDAQ 100?
    • Is Travere Therapeutics in the Dow Jones?
    • When was Travere Therapeutics's last earnings report?
    • When does Travere Therapeutics report earnings?
    • Should I buy Travere Therapeutics stock now?

    What is the ticker symbol for Travere Therapeutics?

    The ticker symbol for Travere Therapeutics is NASDAQ:TVTX

    Does Travere Therapeutics pay dividends?

    No, Travere Therapeutics does not pay dividends

    What sector is Travere Therapeutics in?

    Travere Therapeutics is in the Healthcare sector

    What industry is Travere Therapeutics in?

    Travere Therapeutics is in the Biotechnology industry

    What country is Travere Therapeutics based in?

    Travere Therapeutics is headquartered in United States

    When did Travere Therapeutics go public?

    Travere Therapeutics's initial public offering (IPO) was on November 8, 2012

    Is Travere Therapeutics in the S&P 500?

    No, Travere Therapeutics is not included in the S&P 500 index

    Is Travere Therapeutics in the NASDAQ 100?

    No, Travere Therapeutics is not included in the NASDAQ 100 index

    Is Travere Therapeutics in the Dow Jones?

    No, Travere Therapeutics is not included in the Dow Jones index

    When was Travere Therapeutics's last earnings report?

    Travere Therapeutics's most recent earnings report was on May 1, 2025

    When does Travere Therapeutics report earnings?

    The next expected earnings date for Travere Therapeutics is Aug 1, 2025

    Should I buy Travere Therapeutics stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page